SACC Flummoxed As TSCA Review Ends Without 1,3-BD Cancer Risk Advice

EPA science advisors are struggling to recommend how the agency can strengthen the cancer risk analysis underlying its draft TSCA evaluation for 1,3-buitadiene (1,3-BD) after a top EPA scientist informed them officials lack access to the data the advisors initially said the agency should use and now lacks the time to reevaluate it even if it had it. The Science Advisory Committee on Chemicals (SACC) closed its virtual April 1-4 peer review meeting without reaching a consensus opinion on the...